Literature DB >> 27014975

[Consensus of Chinese experts on diagnosis and treatment of adult primary immune thrombocytopenia (version 2016)].

.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27014975     DOI： 10.3760/cma.j.issn.0253-2727.2016.02.001

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  27 in total

Review 1.  Chinese guidelines for treatment of adult primary immune thrombocytopenia.

Authors:  Xin-Guang Liu; Xiao-Chuan Bai; Fang-Ping Chen; Yun-Feng Cheng; Ke-Sheng Dai; Mei-Yun Fang; Jian-Ming Feng; Yu-Ping Gong; Tao Guo; Xin-Hong Guo; Yue Han; Luo-Jia Hong; Yu Hu; Bao-Lai Hua; Rui-Bing Huang; Yan Li; Jun Peng; Mi-Mi Shu; Jing Sun; Pei-Yan Sun; Yu-Qian Sun; Chun-Sen Wang; Shu-Jie Wang; Xiao-Min Wang; Cong-Ming Wu; Wen-Man Wu; Zhen-Yu Yan; Feng-E Yang; Lin-Hua Yang; Ren-Chi Yang; Tong-Hua Yang; Xu Ye; Guang-Sen Zhang; Lei Zhang; Chang-Cheng Zheng; Hu Zhou; Min Zhou; Rong-Fu Zhou; Ze-Ping Zhou; Hong-Li Zhu; Tie-Nan Zhu; Ming Hou
Journal:  Int J Hematol       Date:  2018-04-04       Impact factor: 2.490

2.  Regulation of Th1/Th2 and Th17/Treg by pDC/mDC imbalance in primary immune thrombocytopenia.

Authors:  Qinzhi Li; Yang Liu; Xiujuan Wang; Mingling Sun; Lei Wang; Xinyou Wang; Ying Liu; Wenxia Fan; Kaile Zhang; Xiao Sui; Xinhong Guo
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-02

3.  [Quantity of Treg cells and Th17 cells in spleen of primary immune thrombocytopenic purpura patients].

Authors:  Y Y Yang; F Q Zhang; Y Pan; F Chen; M J Huang; D Y Zeng; H G Huang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-03-14

4.  [Expression of IL-37 in peripheral blood of adults with primary immune thrombocytopenia].

Authors:  L Liu; K Feng; M L Wang; X H Shu; K S Zhou; H Zhou; X J Liu; Y P Song
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14

5.  [Eltrombopag for the treatment of primary immune thrombocytopenia in 23 pediatric patients].

Authors:  Y T Huang; X F Liu; Y F Chen; R F Fu; W Liu; F Xue; L Zhang; R C Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-12-14

6.  [Clinical efficacy of recombinant activated factor Ⅶ a for 16 hematonosis with moderate or severe bleeding].

Authors:  F Yang; L J Kong; J W Hu; N Liu; Y F Su; Y H Li; J L Chen; Z Y Yu; Z Q Qiao; Q H Wang; M Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-03-14

7.  [Reduction of FXIII during myelosuppression in acute leukemia after chemotherapy and adverse relation with bleeding events].

Authors:  Y Z Wang; B Y Tan; L Li; Z J Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

8.  [A Study on the establishment of immune thrombocytopenia model induced by anti-platelet GPⅠbα antibodies].

Authors:  K X Zhou; R Yan; M X Chen; J Liu; Q Y Cui; R P Hu; Y C Liu; Y Zhang; C G Ruan; K S Dai
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-05-14

9.  [A prospective study of the efficacy and safety of maintenance therapy with recombinant human thrombopoietin in patients with primary immune thrombocytopenia: a multicenter study].

Authors:  H C Cai; S J Wang; L Fu; X M Wang; M Hou; P Qin; F P Chen; X H Zhang; H Huang; J S He; R H Wu; J Y Ma; R C Yang; X F Liu; Y Tian; A J Liu; J S Wu; W W Zhu; Y H Zhou; W B Liu; Y Hu; W J He; Y Li; D Pan; Y Q Zhao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-05-14

10.  [Comparative study between two bleeding grading systems of primary immune thrombocytopenia].

Authors:  S Xiao; Q Liu; M Hou
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.